CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax of $766.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2026-06-30 was $766.00K.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-09-30 was $1.20M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-06-30 was -$2.19M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-03-31 was -$1.17M, a 182.43% decline year-over-year.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 9 month |
|---|---|---|---|---|---|
| 2026-06-30 | $766.00K 10-Q · filed 2026-07-29 | $1.75M 10-Q · filed 2026-07-29 | |||
| 2025-09-30 | $1.20M 10-Q · filed 2025-11-06 | -$993.00K derived: sum of 2 quarters · filed 2026-07-29 | -$2.17M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$2.19M 10-Q · filed 2026-07-29 | -$3.36M 10-Q · filed 2026-07-29 | |||
| 2025-03-31 | -$1.17M 10-Q · filed 2025-05-01 | ||||
| 2024-09-30 | -$2.26M 10-Q · filed 2025-11-06 | -$2.86M derived: sum of 2 quarters · filed 2025-11-06 | -$1.44M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$600.00K 10-Q · filed 2025-07-31 | $823.00K 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | $1.42M 10-Q · filed 2025-05-01 | ||||
| 2023-09-30 | $873.00K 10-Q · filed 2024-10-31 | $1.03M derived: sum of 2 quarters · filed 2024-10-31 | $1.31M 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $161.00K 10-Q · filed 2024-08-01 | $442.00K 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $280.00K 10-Q · filed 2024-04-25 | ||||
| 2022-09-30 | $1.55M 10-Q · filed 2023-10-26 | $3.04M derived: sum of 2 quarters · filed 2023-10-26 | $3.38M 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $1.49M 10-Q · filed 2023-07-27 | $1.84M 10-Q · filed 2023-07-27 | |||
| 2022-03-31 | $346.00K 10-Q · filed 2023-04-27 | ||||
| 2021-09-30 | $929.00K 10-Q · filed 2022-10-27 | $1.32M derived: sum of 2 quarters · filed 2022-10-27 | $2.57M 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $388.00K 10-Q · filed 2022-07-28 | -$388.00K 10-Q · filed 2021-07-29 | $1.64M 10-Q · filed 2022-07-28 | -$1.64M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-05 | -$1.25M 10-Q · filed 2021-04-29 | |||
| 2020-09-30 | -$964.00K 10-Q · filed 2021-10-28 | -$190.00K derived: sum of 2 quarters · filed 2021-10-28 | -$972.00K 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $774.00K 10-Q · filed 2021-07-29 | $8.00K 10-Q · filed 2021-07-29 | |||
| 2020-03-31 | -$766.00K 10-Q · filed 2021-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |